This website uses cookies to ensure you get the best experience on our website. Learn more

Delta Variant Versus Previous COVID 19 Infection vs. Vaccines (Coronavirus Update 128)

x
  • Delta Variant Versus Previous COVID 19 Infection vs. Vaccines

    16:18

    Roger Seheult, MD of MedCram explains how natural immunity (from a previous COVID-19 infection) compares with vaccines (Pfizer, Moderna, AstraZeneca) VS. the Delta coronavirus variant. (This video was recorded on July 24, 2021).

    Correction: Strasbourg is in France (near the German border), not in Germany.

    TOPICS IN THIS VIDEO INCLUDE:

    00:00 Is natural immunity from previous COVID-19 infection strong enough against Delta variant?
    00:32 Research study of 50,000+ patients from the Cleveland Clinic
    03:07 Qatar airport study shows previous infection with SARS-CoV gives reasonable immunity against reinfection
    05:46 UK data suggests low risk of COVID-19 reinfection among population
    07:04 Study on antibody response effectiveness (from vaccines and natural infection) at neutralizing several COVID-19 variants, including Delta
    13:33 Monoclonal antibodies shown to have little effectiveness against Delta variant
    14:31 Patients urged to get both doses of Pfizer or Moderna, especially for protection against Delta variant
    14:59 MedCram resources for medical providers treating COVID-19 patients and the case for lung ultrasounds

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

    See the video Dr. Seheult references about Lung Ultrasound in COVID 19:

    LINKS / REFERENCES:

    Can You Get Delta Variant if You Already Had COVID-19? (Healthline) |

    Necessity of COVID-19 vaccination in previously infected individuals (medRxiv) |

    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar (JAMA) |

    New national surveillance of possible COVID-19 reinfection, published by PHE (GOV.UK) |

    Study highlights need for full Covid vaccination to protect against Delta variant (STAT) |

    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #Deltavariant #Coronavirus

  • x
  • Coronavirus Update 127: Delta Variant and Vaccines

    18:09

    Professor Roger Seheult, MD of MedCram with an update on the effectiveness of four major vaccines against the delta variant of COVID-19: Pfizer / BioNTech, Moderna, AstraZeneca, and Johnson and Johnson Vaccine (This video was recorded on July 19, 2021).

    See the video Dr. Seheult references: 10 Tips if you Get COVID-19 here:

    Please see our most recent video on Previous Infection vs. The Delta Variant:


    TOPICS IN THIS VIDEO INCLUDE:

    00:00 General overview of SARS-CoV-2 variants
    02:44 Characteristics of the SARS-CoV-2 delta variant (B.1.617.2)
    03:21 Preliminary data on delta variant infection rates by age & risk of severe infection
    05:14 How delta variant is affecting COVID-19 case numbers in the UK, Israel, and United States
    06:55 How do the COVID-19 vaccines stack up against delta variant? Effectiveness of Pfizer-BioNTech vaccine
    12:20 Data on the effectiveness of Moderna vaccine against the delta variant
    12:42 Data on effectiveness of Oxford-AstraZeneca vaccine against the delta variant
    13:41 Information on Johnson & Johnson vaccine effectiveness against related SARS-CoV-2 variants (no current data on delta variant)
    15:29 Vaccination rates across the United States
    17:04 What to do if you’re infected with COVID-19?


    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    5 Things To Know About the Delta Variant (Yale Medicine) |

    REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant (Imperial College) |

    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness (The Lancet) |

    Vaccines highly effective against B.1.617.2 variant after 2 doses (GOV.UK) |

    Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant (Public Health England) |

    Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India (Moderna) |

    How much protection COVID-19 vaccines give you against the Delta variant, according to the best available data (Business Insider) |

    The total number and mass of SARS-CoV-2 virions (NIH) |

    Covid vaccine: How many people in the UK have been vaccinated so far? (BBC News) |

    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • x
  • COVID Vaccines VS Delta Variant: State of Texas Study

    20:11

    Roger Seheult, MD of MedCram on the large real world Texas COVID 19 study on coronavirus infections and deaths by vaccination status (Pfizer vs. Moderna. vs. Johnson and Johnson vs. no vaccine). View all Dr. Seheult's videos at:

    (This video is MedCram COVID 19 update 137 and was recorded on November 15, 2021)

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    COVID-19 Cases And Deaths by Vaccination Status (Texas DSHS) |

    Coronavirus Cases (Worldometer) |

    Coronavirus Pandemic (Our World in Data) |


    All coronavirus updates are at MedCram.com (including more discussion on johnson and johnson vaccine, delta plus variant, COVID vaccine, texas department of state health services, astrazeneca vaccine second dose, the COVID delta variant, moderna, pfizer booster, vaccine rollout, blood clots, AstraZeneca second doses, moderna vaccine, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon

    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • Delta Variant: Top 10 COVID Questions and How to Prepare

    22:27

    A coronavirus (COVID-19) variant has become dominant in the USA and Roger Seheult, MD of MedCram responds to 10 common questions including:

    00:00 If someone is fully vaccinated or already had COVID, how worried should they be about the Delta Variant?
    02:16 Should we be getting booster COVID vaccine doses?
    05:36 Will there continue to be more variants, perhaps even variants more challenging that the Delta variant?
    07:24 Is Long COVID occurring in the fully vaccinated?
    08:26 When is this surge going to peak? Can we learn from other countries?
    12:52 Are more children getting hospitalized with COVID 19 Delta variant?
    14:03 What happens when school starts?
    16:06 Have treatment and testing strategies changed for Delta variant?
    19:45 What can we do to protect ourselves and our communities from the coronavirus Delta variant and future COVID mutations?

    This video was recorded on August 6, 2021

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

    Interviewer: Kyle Allred, Physician Assistant, Producer, and Co-Founder of MedCram.com

    LINKS / REFERENCES:

    COVID-19 Ventilator Course:

    Lung Ultrasound in COVID 19:

    Delta Variant vs. Previous COVID-19 Infection | MedCram:

    Delta Variant vs. Vaccines | MedCram:

    10 Tips If You Get COVID-19 | MedCram:

    Worldometer:

    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
    List of authors | NEJM:



    WHO calls for halting COVID-19 vaccine boosters in favor of unvaccinated |

    AMA Physicians Survey |

    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM:

    Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine | MedRxiv:

    The key numbers from the CDC’s new assessment of the delta variant | WP:

    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, Delta variant in US, Delta variant Canada, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #Deltavariant #Coronavirus

  • x
  • Vaccine Efficacy Versus Delta Variant: Real World Data

    10:08

    Roger Seheult, MD of MedCram explains new research on real world vaccine efficacy versus the delta coronavirus variant. The full video Dr. Seheult references:

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

    (This video was recorded on September 23, 2021)

    TOPICS IN THIS VIDEO INCLUDE:

    00:00 Introducing the research - How effective are approved COVID vaccines against Delta variant (United States)?
    00:59 Report from the CDC - Interim Estimates of COVID 19 Vaccine Effectiveness
    02:19 Definitions of “vaccinated,” “unvaccinated,” and “partially vaccinated”
    03:06 Dr. Seheult explains the numbers and data for all COVID vaccines in the United States
    07:56 Breakdown of efficacy by vaccine (Pzifer-BioNTech, Moderna, Janssen/Johnson & Johnson)


    LINKS / REFERENCES:

    Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 (Morbidity and Mortality Weekly Report) |

    MedCram Update 46:

    MedCram Update 47:


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • Innate Immunity, Interferon, and COVID 19 in Children: Update 128

    11:46

    Professor Roger Seheult, MD of MedCram on the role of interferons to protect against severe coronavirus infections, and why children typically have milder COVID symptoms than adults (this video was recorded on August 25, 2021).

    See the video Dr. Seheult references: 10 Tips if you Get COVID-19 here:

    Please see our most recent video on The Delta Variant and Vaccines:

    TOPICS IN THIS VIDEO INCLUDE:

    00:00 New daily COVID-19 cases are on the rise in the United States
    00:31 What can we learn from kids’ immune systems to protect ourselves from COVID-19 hospitalization?
    01:07 Innate immune system and interferon -- why they’re important
    01:49 Impaired interferon activity & inflammatory responses in severe COVID-19 patients
    03:38 Interferon found to be “crucial” for mitigating SARS-CoV-2 infection & why kids express greater antiviral activity against COVID-19 than adults
    07:06 Are there ways to improve the body’s ability to secrete interferon? Hydrotherapy & fevers
    08:46 1918 Influenza Pandemic, Dr. Wells Ruble, & reducing fatality with hydrotherapy
    09:32 “The Swiss Cheese Respiratory Virus Pandemic Defence Model” & protection against SARS-CoV-2

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children (Nature Biotechnology) |

    Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19 (Medical Hypotheses) |

    Hydrotherapy at Home (Health Education Resources) |

    Hydrotherapy for COVID-19 (HYDRO4COVID) |

    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more).

    MedCram Update 46:

    MedCram Update 47:


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • x
  • The Delta Variant: Current Evidence and Literature - COVID-19 | SARS-CoV-2 | Vaccine Efficacy

    1:11:44

    Official Ninja Nerd Website:
    Ninja Nerds!

    In this lecture Professor Zach Murphy will be presenting on The Delta Variant: Current Evidence and Literature - COVID-19 | SARS-CoV-2 | Vaccine Efficacy- as of August 16, 2021.

    During this lecture we will be providing you with the most up to date evidence and literature discussing the Delta Variant and current state of the COVID-19 pandemic. We will begin this lecture by referring to the whiteboard on the current variants of concern and their pathophysiology. Next, we will take a look at current research supporting variants of concern and their relevant attributes. We will then be discussing the research defining the viral load of the Delta variant, and will then support this with evidence from a variety of reputable sources including UpToDate and the CDC. The next chapter of this lecture is a brief discussion on the overall transmissibility of the Delta variant. We look at the transmissibility or the spreadability of this Delta variant in comparison to ancestral strains and the Alpha variant. We will support these findings with current evidence on transmissibility from Public Health England and the CDC. Following this discussion, we move into the severity of the Delta variant in comparison to ancestral strains and the Alpha variant. Once again, we utilize the whiteboard and recently published articles to support our findings on the severity of the Delta variant. We will then transition into the prevalence / most affected populations in regard to the Delta variant. We support our lecture through the use of articles / research studies published by Public Health England, CDC, and The New York Times. The next chapter of our lecture is a discussion on the symptoms and treatment of COVID-19, particularly those affected by the Delta variant. We highlight the different symptoms patients are presenting with in comparison to ancestral strains and the Alpha variant. Finally, we conclude this lecture with a very important discussion on vaccine efficacy, and the potential risk of reinfection rates in regard to the Delta variant. We hope you enjoy this lecture and be sure to support us below!

    References:

    Table of Contents:
    0:00 Lab
    0:08 The Delta Variant Introduction
    0:40 Variants of Concern / Pathophysiology
    8:42 Viral Load
    10:44 Transmissibility
    14:27 Severity
    18:55 Prevalence / Populations Affected
    28:32 Symptoms associated with Delta Variant
    33:04 Treatment of COVID-19
    45:43 Vaccine Efficacy | Pfizer/BioNTech + Moderna + AstraZeneca
    1:01:14 Prevention, Masks, NPI
    1:04:20 Reinfection Rates
    1:10:09 Comment, Like, SUBSCRIBE!

    Join this channel to get access to perks:


    APPAREL |


    DONATE
    PATREON |
    PAYPAL |

    SOCIAL MEDIA

    FACEBOOK |

    INSTAGRAM |

    TWITTER |
    @NinjaNerdSci

    DISCORD |

    #ninjanerd #covid_19 #deltavariant

  • Fact check: Do COVID-19 vaccines protect against the delta variant? | DW News

    6:04

    Worldwide, some people died of the delta variant despite being fully vaccinated. Is the COVID-19 vaccination no longer sufficient? A look at the facts shows: Yes, complete vaccinations are still the best protection you can get against delta.

    Key sources:








    Subscribe:

    For more news go to:
    Follow DW on social media:
    ►Facebook:
    ►Twitter:
    ►Instagram:
    Für Videos in deutscher Sprache besuchen Sie:
    #CovidVaccine #DeltaVariant #FactChecking

  • COVID-19 Delta Variant - Masks for Fully Vaccinated People Explained

    4:00

    Dr. Stuart Cohen, Director of Hospital Epidemiology and Infection Control at UC Davis Medical Center, explains why the COVID-19 Delta variant is more easily transmitted than previous variants, how masks should still play a role in keeping you safe (even if you are vaccinated) and why getting a COVID-19 vaccine is vital for preventing future variants of the novel coronavirus.

    Learn more about Delta and masking:
    For the latest information and resources on COVID-19, visit
    See the latest news from UC Davis Health:

    #covid19 #deltavariant #coronavirus #delta #ucdavis

  • x
  • Natural versus vaccine immunity

    21:55

    Post infection natural immunity, debate and implications for mandatory vaccination



    US as of 11th December 2020



    US, Natural infection, Feb 2020 to May 2021

    0 – 17 26.8 / 73 37%

    18 – 49 60.5 / 138 44%

    50 – 64 20.4 / 62 32%

    65+ 12.3 / 54 23%

    Total 120.3/ 328 37%

    Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection



    N = 254 blood samples post infection

    N = 51 long term follow up

    Antibodies against SARSCoV-
    2 spike and receptor binding domain
    (RBD) declined moderately over 8 months

    Memory B cells against SARS-CoV-2 spike
    increased between 1 month and 8 months
    after infection.

    Proportion of subjects positive for CD4+ T cells (92%) remained high at 6 to 8 months after infection.

    The different types of immunememory each had distinct kinetics, resulting in complex interrelationships over time

    CONCLUSION

    Substantial immune memory is generated after COVID-19

    About 95% of subjects retained immune memory at ~6 months after infection

    Circulating antibody titers were not predictive of T cell memory

    CDC

    Still recommends a full vaccination dose for all

    the immune response from vaccination is more predictable

    antibody responses after infection vary widely by individual

    June, Peter Marks, Food and Drug Administration’s Center for Biologics Evaluation and Research

    We do know that the immunity after vaccination is better than the immunity after natural infection

    generally the immunity after natural infection tends to wane after about 90 days



    It appears from the literature that natural infection provides immunity,

    but that immunity is seemingly not as strong and may not be as long lasting as that provided by the vaccine

    UK covid pass guidelines



    proof of natural immunity shown by a positive PCR test result for COVID-19, lasting for 180 days after the date of the positive test

    Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel



    Vaccination was highly effective

    Estimated efficacy for documented infection of 92·8%

    Hospitalization 94·2%

    Severe illness 94·4%

    Death 93·7%

    Protection from prior SARS-CoV-2 infection

    Estimated efficacy for documented infection of 94·8%

    Hospitalization 94·1%

    Severe illness 96·4%

    Ministry of Health during summer surge

    Between 5 July and 3 August

    (over half a million infected but unvaccinated)

    Just 1% of weekly new cases were in people who had previously had covid-19

    Dvir Aran, biomedical data, Technion–Israel Institute of Technology

    these numbers look very low

    the data suggest that the recovered have better protection than people who were vaccinated

    Systemic side-effects were more common in people previously infected



    Large UK study

    1·6 times after the first dose of ChAdOx1 nCoV-19

    2·9 times after the first dose of BNT162b2

    56% more likely to experience a severe side effect that required hospital care

    Conclusion

    Public health strategy versus individualised medicine

  • Pfizer developing Covid-19 vaccine booster targeting Delta variant

    3:15

    CNBC's Meg Tirrell reports on Pfizer's update regarding its Covid-19 booster shot.

  • COVID Delta Variant: Booster Shots, Nasal Vaccine, Rapid Testing, with Eric Topol, MD

    16:08

    A leading scientist discusses COVID testing in the US, booster shots, how contagious and dangerous the Delta variant is, new vaccine technology, and what we can do to protect ourselves from coronavirus infection and hospitalization. (Recorded Aug 11, 2021)

    TOPICS IN THIS VIDEO INCLUDE:

    00:00 Introducing Dr. Eric Topol, Physician-Scientist, Author, and Professor
    00:44 Main ideas behind Dr. Topol’s article, “America if flying blind when it comes to the Delta variant”
    01:49 How do surveillance and testing in the US compare to other countries experiencing Delta variant surge?
    03:03 Benefits of rapid COVID-19 testing and why we haven’t adopted it in the United States
    05:02 What’s “special” about Delta variant, and what really are “breakthrough” infections?
    06:50 What are “intranasal vaccines,” and what are their advantages against highly transmissible viruses, like the Delta variant?
    09:37 Dr. Topol’s stance on “booster shots” of current vaccines versus new, targeted vaccines
    11:31 Hospitalizations in United States compared to Israel and UK per capita -- why these numbers are alarming
    13:18 How contagious is the Delta variant compared to other viruses?
    14:12 How have perspectives changed with regard to mask-wearing and physical distancing?
    14:59 Importance of taking care of our immune systems

    Eric Topol, MD is the Founder and Director, Scripps Research Translational Institute; and the Executive Vice President and Professor of Molecular Medicine, Scripps Research. Dr. Topol has published over 1,200 peer-reviewed articles and is one of the top 10 most cited researchers in medicine. He was the first physician researcher to raise questions about the safety of Vioxx and testified against the medication's manufacturer: Merck.

    Interviewer: Kyle Allred, Physician Assistant, Producer, and Co-Founder of MedCram.com

    LINKS / REFERENCES:

    America is flying blind when it comes to the Delta variant | The Guardian:

    At Home COVID-19 Testing with Dr. Mina |



    Germany Makes Rapid Virus Tests a Key to Everyday Freedoms | New York Times:

    To Beat COVID, We May Need a Good Shot in the Nose | Scientific American:

    Scent of a Vaccine | Science:

    (Dr. Topol's Twitter Page)


    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, COVID 19 Delta Variant, Eric Topol coronavirus, rapid antigen testing, nasal vaccines, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Interview Produced and Edited by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #Deltavariant #Coronavirus

  • COVID-19: Levels of Delta variant same in vaccinated people

    3:41

    Coronavirus levels in people with the COVID Delta variant may be similar regardless of whether or not they've been vaccinated, according to early research.

    Researchers stress more time is needed to better analyse the data.

    But if true, the findings may have implications for people's infectiousness, whether they've been vaccinated or not.

    SUBSCRIBE to our YouTube channel for more videos:

    Follow us on Twitter:

    Like us on Facebook:

    Follow us on Instagram:

    For more content go to and download our apps:

    Apple:

    Android

    Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí

  • Delta Plus Variant Likely To Defeat Vaccines And Infection Immunity? Experts Believe So

    3:44

    But now there is a growing concern about its most recent mutation known as Delta Plus or AY.01. Reports suggest the Delta Plus variant could evade both vaccine and infection immunity. Meanwhile, the Union health ministry has still not classified the Delta plus variant as a ‘variant of concern’
    #deltaplus #deltaplusinindia #thirdwave

    Follow CRUX on Instagram (@crux.india):
    Follow CRUX on Facebook:
    #GetCloserToTheNews with latest headlines on politics, sports and entertainment on news18.com

    Also watch:
    Crux One Take:
    Crux Files:
    Crux BTS:

  • Delta Covid variant In Israel Infects Some Fully Vaccinated Adults

    3:20

    Israel began relaxing its Covid-19 restrictions after a widely successful vaccine rollout, but some fully vaccinated adults have caught the virus, raising concerns that the delta variant is spreading through the country. NBC News’ Raf Sanchez is in Tel Aviv to explain how Israel is trying to contain variant outbreaks.  

    » Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:
    Follow NBC News on Instagram:

    #DeltaVariant #Israel #Coronavirus

  • Natural and Vaccine Immunity against Delta | UK and Israel implication for the US |CDC leaked report

    16:01

    #DeltaVariant #NewWave #NatrualvsVaccineImmunity

    Hi everyone, welcome and welcome back this week! Many of you may have questions about reinfection and in particular reinfection from the Delta variant. Let's look at what we know so far.
    At the end, I have also concluded the latest leaked CDC report.

    If you appreciate my work, you can buy me a coffee. :)


    Disclaimer:

    This video is Dr. Hong’s interpretation and summary of publically available scientific information
    This video is not intended to serve as any advice regarding the treatment, prevention, and diagnosis of any diseases
    Dr. Hong has no connections and receives no monetary compensation from any pharmaceutical companies and government.
    This video is for educational purposes only.

    -------------------------------
    To learn more:
    Bridging between Innate and Adaptive Immune Systems


    -------------------------------
    Source References:
    Necessity of COVID-19 vaccination in previously infected individuals




    Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study 


    SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans


    Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers


    SARS-CoV-2 re-infection risk in Austria




    Public Health England


    Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization


    Report from CNBC




    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant




    CDC Leaked Report

  • The Delta Variant, Vaccine Effectiveness and Development of Intranasal COVID-19 Vaccines

    10:37

    How dangerous is the Delta variant? Do vaccines remain protective against Delta? Why are fully vaccinated people still transmitting the virus? What can be done to slow viral evolution?

    In this race for survival of the fittest, Delta, which the World Health Organization has called the “fastest and fittest variant so far,” has given the virus an edge. Thanks to a series of mutations in the spike protein, the portion of the virus that binds to human ACE2 receptors and mediates viral entry, Delta is 40-60% more transmissible than Alpha and almost twice as transmissible as the original Wuhan strain.

    The key is to get ahead of the natural selection that’s occurring. If we want to stop SARS-CoV-2 from continuing to evolve and spread, we need to simultaneously reduce case numbers and increase immunity.

    Takeaways from today’s session about the SARS-CoV-2 Delta variant, vaccines and mucosal immunity:

    - The Delta variant is 40-60% more transmissible than Alpha and almost twice as transmissible as the original Wuhan strain.

    - Vaccines remain highly effective at preventing hospitalization and death from Delta infection.
    Data indicate that vaccinated individuals may still be able to transmit the virus.

    - This is due, in part, to the generation of insufficient mucosal immunity via systemic injection to remain protective long term.

    - Mucosal routes of immunization are under investigation, with a number of intranasal vaccines entering clinical trial.

    In combination, vaccination and masking can reduce the risk of severe disease, slow transmission and reduce the evolution of SARS-CoV-2.

    Sources:
















    ???? Subscribe to ASM's YouTube channel at

    ???? Learn more about the American Society for Microbiology at

    ✅ Become a member today at

    ???? Join us on social:

    Facebook:

    Twitter:

    Instagram:

  • Coronavirus Vaccines vs. NON COVID-19 related deaths

    24:20

    Roger Seheult, MD of MedCram discusses lower non COVID-19 death rates in COVID-19 vaccine recipients.
    Interesting new data published in MMWR by the CDC. MedCram COVID 19 Update 135

    (This video was recorded on November 8, 2021)

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 (CDC) |

    COVID Vaccine Myths, Questions, and Rumors with Rhonda Patrick and Roger Seheult (MedCram) |

    All coronavirus updates are at MedCram.com (including more discussion on the COVID delta variant, moderna, pfizer booster, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon

    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • Should Vaccinated People Be Concerned About The Delta Variant?

    3:23

    NBC News medical contributor Dr. Kavita Patel explains whether vaccinated people should resume wearing masks as the delta variant intensifies its spread across the U.S.» Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.


    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:
    Follow NBC News on Instagram:


    #Delta #Vaccines #Covid

    Should Vaccinated People Be Concerned About The Delta Variant?

  • COVID-19 Delta Variant Survivor Grateful for Vaccine

    1:48

    A COVID-19 delta variant survivor hopes his personal experience will convince others to roll up their sleeve and get vaccinated. Ginger Conejero Saab reports.

    Stay connected:
    Follow us on Twitter:
    Like us on Facebook:
    Follow us on Instagram:
    Add us on Snapchat @NBCBayArea

    Catch up on all the day's news:

    Download our app:
    On iOS:
    On Android:

  • x
  • Natural immunity key in US

    15:30

    USA, Natural immunity key



    Nationwide Blood Donor Seroprevalence Survey

    Data, gathered from blood donors

    Estimates of population, 16 and older, have developed antibodies

    Vaccination or infection?

    March 21st 2021

    Seroprevalence, 49.1%

    Over 16 vaccinated, 13.7%

    Cumulative reported cases, 8.7%

    Deaths as of 21 March



    550,559

    US population, 330 million

    Total infections, 162,000,000

    Infection fatality rate, 0.4% (0.33985)

    Infection fatality rate as of 21st March

    Now, herd immunity

    Adults with at least one vaccine dose, 64.7%

    US hospitalizations



    Total now, 2,255,380

  • The Coronavirus Pandemic: The Delta Variant Surge

    47:08

    The highly infectious COVID-19 Delta variant is spurring global surges, sparking concerns among public health officials. In the U.S., more than 80 percent of new cases are from the Delta variant. What makes this variant so contagious? How protective are current vaccines? What’s the latest on practices such as masking and social distancing? Join Harvard Chan epidemiologist William Hanage and The World’s Carolyn Beeler for this online Q&A.

    Presented jointly with The World from PRX & GBH.

  • What You Need to Know About the Delta Variant

    7:25

    Several COVID-19 variants are acting uniquely enough to qualify as a distinct strain. And you might have heard about one on the news: the Delta variant. Today we’re going to talk about what it is, why it’s here, and what you need to know about it.

    Hosted by: Hank Green

    SciShow has a spinoff podcast! It's called SciShow Tangents. Check it out at
    ----------
    Support SciShow by becoming a patron on Patreon:
    ----------
    Huge thanks go to the following Patreon supporters for helping us keep SciShow free for everyone forever:

    Chris Peters, Matt Curls, Kevin Bealer, Jeffrey Mckishen, Jacob, Christopher R Boucher, Nazara, charles george, Christoph Schwanke, Ash, Silas Emrys, KatieMarie Magnone, Eric Jensen, Adam Brainard, Piya Shedden, Alex Hackman, James Knight, GrowingViolet, Sam Lutfi, Alisa Sherbow, Jason A Saslow, Dr. Melvin Sanicas

    ----------
    Looking for SciShow elsewhere on the internet?
    Facebook:
    Twitter:
    Tumblr:
    Instagram:
    ----------
    Sources:





































  • Coronavirus Update 123: COVID 19 Vaccines vs. Variants

    10:42

    How well will COVID-19 vaccines work against the coronavirus variants first discovered in the UK, South Africa, and Brazil? Dr. Seheult discusses the research we have so far on SARS CoV 2 mutations. (This video was recorded on February 23, 2021).

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    COVID: UK variant spreading rapidly in Germany (DW) |

    Germany: Schools reopen for younger children amid rising COVID infections (DW) |

    Where schools are reopening in the US (CNN) |

    Adapted booster vaccines in the works (Medical News Today) |

    Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera (Science) |

    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (Cell) |

    mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (bioRxiv) |

    Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa (Moderna) |


    THE MEDCRAM WEBSITE:

    Visit us for videos on over 60 medical topics and CME / CEs for medical professionals:


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon:


    RECENT PREVIOUS COVID-19 UPDATES:

    Please visit MedCram.com for the full series:
    - Coronavirus Update 122: The Research So Far on COVID-19 and Vaccines vs. Pregnancy
    - Coronavirus Update 121: Johnson and Johnson Vaccine - Efficacy and Safety vs. Pfizer & Moderna
    - Coronavirus Update 120: Anticoagulants (Blood Thinners) Improve Hospital Outcomes (Full Dose)
    - Coronavirus Update 119: Pfizer BioNTech COVID Vaccine (Clinical Considerations)
    - Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)
    - Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. Pfizer / BioNTech, Moderna mRNA vaccines)

    All coronavirus updates are at MedCram.com (including more discussion on COVID variants, COVID mutations, and more).

    We offer over 60 medical topics (ECG Interpretation, DKA, influenza, measles, mechanical ventilation, etc.) on our website.


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and a variety of medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred

    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.
    #COVID19 #SARSCoV2

  • The COVID-19 Delta Variant Explained

    3:11

    Dr. Lorena Garcia, professor of epidemiology at UC Davis School of Medicine, explains how the COVID-19 Delta variant is different, what you can do to stay safe and how vaccines could make a difference in preventing future COVID-19 variants.

    Learn more about the Delta variant:
    For the latest information and resources on COVID-19, visit
    See the latest news from UC Davis Health:

    0:00 What should we know about the COVID-19 Delta variant?
    0:57 How does the Delta variant compare to other COVID-19 variants?
    1:58 How do vaccines affect COVID-19 variants?

    #delta #deltavariant #covid19 #coronavirus #ucdavis

  • AstraZeneca Second Doses vs Moderna and Pfizer COVID Vaccines

    8:04

    Roger Seheult, MD of MedCram discusses new AstraZeneca coronavirus vaccine data and compares second doses of the Oxford AZ vaccine with Pfizer and Modera vaccines. View all Dr. Seheult's videos at:

    (This video is MedCram COVID-19 update 136 and was recorded on November 9, 2021)

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


    LINKS / REFERENCES:

    AstraZeneca’s COVID-19 vaccine: benefits and risks in context (European Medicines Agency) |

    Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study (ScienceDirect) |

    Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. Pfizer / BioNTech, Moderna) (MedCram) |

    All coronavirus updates are at MedCram.com (including more discussion on astrazeneca vaccine second dose, the COVID delta variant, moderna, pfizer booster, vaccine rollout, blood clots, AstraZeneca second doses, moderna vaccine, and more).


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon

    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Video Produced by Kyle Allred


    FOLLOW US ON SOCIAL MEDIA:






    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #SARSCoV2 #Coronavirus

  • COVID Vaccine Myths, Questions, and Rumors with Rhonda Patrick and Roger Seheult

    2:23:36

    Dr. Patrick joins MedCram to discuss COVID 19 vaccines, spike protein, ivermectin, VAERS, breakthrough Infections, antibody dependent enhancement, fertility, delta variant, myocarditis, fluvoxamine, optimizing immunity, and more.

    Dr. Rhonda Patrick is a cell biologist with a Ph.D. in biomedical science from the University of Tennessee Health Science Center and St. Jude Children's Research Hospital. Dr. Patrick is the Co-Founder of FoundMyFitness.com. Subscribe to Dr. Patrick's YouTube channel here:

    Roger Seheult, MD is the co-founder and lead professor at
    He is an Associate Professor at the University of California, Riverside School of Medicine and Assistant Professor at Loma Linda University School of Medicine.
    Dr. Seheult is Quadruple Board Certified: Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine.

    Interviewer: Kyle Allred, Physician Assistant, Producer, and Co-Founder of MedCram.com

    This conversation was recorded September 9, 2021

    Topics covered:
    00:00:00 - Introducing Dr. Rhonda Patrick and Dr. Seheult
    00:01:20 - Should young and healthy get vaccinated?
    00:06:47 - Risk of myocarditis
    00:10:40 - Long-haul COVID
    00:19:58 - Is spike protein from vaccines dangerous?
    00:35:39 - COVID-19 Vaccine Adverse Event Reporting System (VAERS)
    01:01:17 - Antibody dependent enhancement?
    01:09:16 - Do COVID vaccines damage fertility?
    01:14:13 - Will mRNA vaccines alter DNA?
    01:22:32 - Are alternatives like ivermectin as effective as the vaccine?
    01:42:02 - Do vaccines prevent Delta transmission?
    01:56:04 - Will the virus become more deadly due to vaccines?
    02:05:07 - T-cell immunity
    02:08:34 - Long term side effects / were vaccines rushed?


    SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:


    Get notified of new videos by hitting the bell icon.


    FOLLOW DR. RHONDA PATRICK
    YouTube:
    Twitter:
    Podcast:


    MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

    MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.


    MEDIA CONTACT:

    Media Contact: customers@medcram.com
    Media contact info:

    Interview Produced and Edited by Kyle Allred and Dan Patrick


    FOLLOW US ON SOCIAL MEDIA:





    All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, delta plus variant COVID, COVID delta variant, moderna vaccine, and more).

    DISCLAIMER:

    MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

    #COVID19 #Deltavariant #Coronavirus

  • Covid-19: Can vaccines keep up with variants? | The Economist

    6:32

    The race between covid-19 vaccines and variants is on. Alok Jha, The Economist’s science correspondent, and Natasha Loder, health policy editor, discuss what this means for the future

    Read more of our coverage on coronavirus:

    Listen to our daily podcast, Gamechangers, on mRNA technology:

    Listen to “The Jab” podcast from Economist Radio:

    Watch our film about mandatory vaccines:

    Which countries are considering a booster jab?

    Why are covid variants named using the Greek alphabet?

    Can vaccines help solve environmental issues?

    Why is the Delta variant the most dangerous mutation yet?

    What’s Britain’s strategy for mass vaccination?

    Where will you need proof of vaccination?

    How the pandemic has brought re-examination of intellectual-property rights:

    Why are the unvaccinated at risk?

    Which vaccine is the most widely accepted for international travel?

  • Israel, UK, Delta Variant, and Vaccines

    42:53

    Please read and agree to the disclaimer before watching this video.
    . Israel, UK, Delta Variant, and Vaccines

    Two shot vaccine efficacy in Israel is dropped against the delta variant. Good news is that the efficacy against the hospitalization and severe disease is still very high. On a related note, Pfizer-BioNTech are looking to offer a booster dose. Let’s review the data.

    Buy me a coffee :-)
    Become my patron:
    Looking to support my educational work? Donate here:
    Join us on Discord:

    Hebrew language report from Israel’s health ministry:

    Article about the vaccine efficacy in Israel:

    A good article about the vaccine sand Isreal:

    Dr. Michal Stein: The number of patients in Aliyah - we may have to reopen the Corona ward.”


    Isreal cases on worldometer


    UK cases on worldometer


    Why are the UK cases dropping?


    Vaccine efficacy in UK is high against the delta variant.


    Vaccination tracker


    #COVID19 #VACCINES #DELTAVARIANT ...

    Disclaimer:
    This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
    Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...

    Disclaimer:
    This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
    Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
    Disclaimer:
    This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
    Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

  • CDC: Fully-vaccinated people can still spread the delta variant

    2:21

    CNBC's Meg Tirrell reports on the CDC's new warning that the delta variant of Covid is as contagious as the chicken pox. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

    About three-fourths of people infected in a Massachusetts Covid-19 outbreak were fully vaccinated against the coronavirus with four of them ending up in the hospital, according to new data published Friday by the Centers for Disease Control and Prevention.

    The new data, published in the U.S. agency’s Morbidity and Mortality Weekly Report, also found that fully vaccinated people who get infected carry as much of the virus in their nose as unvaccinated people, and could spread it to other individuals.

    “This finding is concerning and was a pivotal discovery leading to CDC’s updated mask recommendation,” CDC Director Dr. Rochelle Walensky said in a statement. “The masking recommendation was updated to ensure the vaccinated public would not unknowingly transmit virus to others, including their unvaccinated or immunocompromised loved ones.”

    On Tuesday, the CDC reversed course on its prior guidance and recommended fully vaccinated Americans who live in areas with high Covid infection rates resume wearing face masks indoors. The guidelines cover about two-thirds of the U.S. population, according to a CNBC analysis.

    While the delta variant continues to hit unvaccinated people the hardest, some vaccinated people could be carrying higher levels of the virus than previously understood and are potentially transmitting it to others, Walensky told reporters on a call Tuesday. She added the variant behaves “uniquely differently from past strains of the virus.”

    A CDC document that was reviewed by CNBC warned that the delta variant sweeping across the country is as contagious as chickenpox, has a longer transmission window than the original Covid strain and may make older people sicker, even if they’ve been fully vaccinated.

    Delta, now in at least 132 countries and already the dominant form of the disease in the United States, is more transmissible than the common cold, the 1918 Spanish flu, smallpox, Ebola, MERS and SARS, according to the document. Only measles appears to spread faster than the variant.

    The data published Friday was based on 469 cases of Covid associated with multiple summer events and large public gatherings held in July in Barnstable County, Massachusetts, which encompasses Cape Cod and is just outside Martha’s Vineyard. The events were held in Provincetown, according to NBC News. Approximately three-quarters, or 74%, of the cases occurred in fully vaccinated people who had completed a two-dose course of the mRNA vaccines or received a single shot of Johnson & Johnson’s.

    Overall, 274 vaccinated patients with a breakthrough infection were symptomatic, according to the CDC. The most common side effects were cough, headache, sore throat, muscle pain and fever. Among five Covid patients who were hospitalized, four were fully vaccinated, according to the agency. No deaths were reported.

    Testing identified the delta variant in 90% of specimens from 133 patients.

    While numerous studies have shown that the vaccines don’t work as well against the delta variant as they did against other strains, health officials say they are still highly effective, especially in protecting against severe illness and death. Roughly 97% of new hospitalizations and 99.5% of deaths in the U.S. are among unvaccinated individuals, U.S. health officials repeated this week.

    » Subscribe to CNBC TV:
    » Subscribe to CNBC:
    » Subscribe to CNBC Classic:

    Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

    The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:

    Connect with CNBC News Online
    Get the latest news:
    Follow CNBC on LinkedIn:
    Follow CNBC News on Facebook:
    Follow CNBC News on Twitter:
    Follow CNBC News on Instagram:



    #CNBC
    #CNBCTV

  • COVID-19 Update: The Delta Variant and Kids

    13:48

    ► How bad is the Delta variant? And should you get your teen son vaccinated? Dr. Jason Bowling addresses the latest questions about COVID-19 and recent reports on myocarditis as a potential vaccine side effect. Sneak preview: we actually see more – and worse – heart inflammation when kids are infected with the disease.

    00:00 - How prevalent has the Delta variant become in San Antonio?
    00:44 - What is involved in isolating variants?
    01:25 - How much worse is the Delta variant from other COVID-19 strains?
    02:01 - What part of the population are we seeing hospitalized for COVID-19 now in early summer 2021?
    02:41 - How protective are the authorized vaccines against the Delta variant?
    03:01 - Can you get the Delta variant even if vaccinated?
    04:27 - Is one shot of Pfizer or Moderna enough to protect me from Delta?
    05:10 - When do we think a vaccine might be authorized for the under 12 age group?
    05:43 - What would you tell your family to explain how much more serious this is than a cold or the flu?
    06:21 - How protected are you from the Delta variant if you have had COVID-19 but not been vaccinated?
    07:16 - How many other variants are out there, and what makes the Delta variant so concerning?
    08:10 - If we’ve already been vaccinated, what else can we do to protect others?
    08:54 - What are myocarditis and pericarditis?
    09:22 - Some people have not gotten their children the second shot because they are concerned about myocarditis/pericarditis. How concerned should we be about heart problems related to the vaccine in young people?
    11:00 - People have not been as worried about children being affected by COVID-19. Why is that not a good idea, especially with the Delta variant?
    12:03 - Which is more common and serious: side effects of the vaccine or the impact of COVID-19?
    12:39 - It has been such a relief to take off our masks and socialize again. But are there some precautions we should still observe?

  • Delta, double hospital risk

    24:10

    NZ, Australia and Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study



    Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study





    Public Health England (PHE) and Medical Research Council

    SARS-CoV-2 delta (B.1.617.2) first detected in England in March, 2021

    Suspected to cause more severe disease than alpha (B.1.1.7)

    Determining the relative risk of hospital attendance

    England between March 29 and May 23, 2021

    All infected with alpha or delta

    Public Health England’s Second-Generation Surveillance System

    COVID-19-associated deaths dataset

    National Immunisation Management System

    NHS Digital Secondary Uses Services and Emergency Care Data Set

    Infections

    n = 43,338 COVID-19-positive patients

    Most patients were unvaccinated, 32,078 (74·0)

    Median age 31, (IQR, 17 – 42)

    Delta = 8,682

    Alpha = 34,656

    Admitted to hospital or sought emergency care within 14 days of positive test

    Delta = 498 (5.7%)

    Alpha = 1,448 (4·2%)

    Adjust for age, sex, ethnicity, deprivation, recent international travel, area of residence, calendar week, and vaccination status

    HR for attendance at emergency care or hospitalisation = 1.45

    HR for hospital admission = 2.26

    In the subgroup of vaccinated patients

    No significant difference between variants for emergency visit or hospitalisation

    Interpretation

    This large national study found a higher hospital admission or emergency care attendance risk for patients with COVID-19 infected with the delta variant compared with the alpha variant.

    Results suggest that outbreaks of the delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variant.

    PHE studies and protection against hospital admission



    96% for the Pfizer-BioNTech vaccin

    92% for the Oxford-AstraZeneca vaccine

    UK rates

    47.9 million people, (88%) aged 16 and over, first dose of a vaccine

    42 million people, (78%) aged 16 and over, have had a second

    Dr Gavin Dabrera, PHE

    We already know that vaccination offers excellent protection against Delta and, as this variant accounts for over 99% of Covid cases in the UK, it is vital that those who have not received two doses of vaccine do so as soon as possible

    It is still important that if you have Covid symptoms, stay home and get a PCR test as soon as possible

    Lancet study findings are consistent with Scottish data



    Comparing Alpha and Delta risks.


    USA, MAB therapy

    FDA, EUA

    Florida, 21 popup sites

    (via injection shots)

    Dr. Fauci, can reduce deaths by 85%

    If early enough in the infection

    Lowers viral load

    Texas, Missouri, Iowa

    Observe for one hour

  • Where the Covid delta variant has its highest transmission rates in the U.S.

    3:56

    CNBC's Meg Tirrell reports on the Delta variant of Covid-19 and the latest numbers of its transmission and spread across the United States. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

    The delta variant’s “rapid rise is troubling,” CDC director Dr. Rochelle Walensky said of the dangerous Covid strain in a White House press briefing Thursday.

    The more transmissible delta variant is now the most dominant strain of the coronavirus in the United States, representing over 50% of cases across the country, according to data released by the Centers for Disease Control and Prevention Wednesday.

    Pfizer and BioNTech announced Thursday that they are developing a booster shot to target the delta variant. The authorized Covid vaccines appear to work well at preventing severe disease, hospitalization and death from the delta variant. But pockets of the country remain unvaccinated and therefore at risk.

    Delta’s speed and high transmissibility makes it able to “pick off the more vulnerable more efficiently than previous variants,” Dr. Mike Ryan, executive director of the WHO’s health emergencies program, said during a news conference on June 21.

    Getting fully vaccinated is the best way to protect yourself from the delta variant.

    Here’s what else you need to know about the strain:

    Vaccinated people can get breakthrough infections

    In theory, vaccinated people can still get a breakthrough infection. However, White House chief medical advisor Dr. Anthony Fauci said it’s unlikely that a vaccinated person could transmit the virus because the amount of virus in their system would be so low.


    ″[W]e are looking at situations where you have vaccinated people who have breakthrough infections,” the White House chief medical advisor told Chuck Todd during an interview with NBC’s “Meet the Press” on July 4. “Namely, they’re infected despite the fact that they’ve been vaccinated.”

    It’s important to note, however, that vaccinated people who get infected have significantly less virus in their nasopharynx, Fauci said.

    “When you look at the level of virus to be lower, that would mean you could make a reasonable assumption that those individuals would be less likely to transmit the infection to someone else,” he said.

    Delta is already causing Covid spikes in parts of the U.S. and could cause ‘major outbreaks’ this fall

    To date, 47.6% of the U.S. population is fully vaccinated. But delta is surging in pockets of the country where vaccine rates are concerningly low such as the South and Midwest. In some parts of the Midwest and upper mountain states, delta accounts for 80% of Covid cases, Walensky said in the press briefing.

    Virtually all new Covid deaths and hospitalizations are among unvaccinated people.

    ″[T]here will likely continue to be an increase in cases among unvaccinated Americans and in communities with low vaccination rates, particularly given the spread of the more transmissible Delta variant,” White House coronavirus response coordinator Jeff Zients said at a press briefing on Thursday.

    Lawrence Gostin, director of the World Health Organization’s Collaborating Center on National and Global Health Law, told CNBC that there could be “major outbreaks” in the fall, just as many people are going back to offices and schools.

    That said, a nationwide spike like the U.S. witnessed last fall and winter is unlikely given the proportion of people who are now vaccinated, Fauci said.

    » Subscribe to CNBC TV:
    » Subscribe to CNBC:
    » Subscribe to CNBC Classic:

    Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

    The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:

    Connect with CNBC News Online
    Get the latest news:
    Follow CNBC on LinkedIn:
    Follow CNBC News on Facebook:
    Follow CNBC News on Twitter:
    Follow CNBC News on Instagram:



    #CNBC
    #CNBCTV

  • COVID-19 variants mu, delta and what to know about mutations

    2:07

    A new COVID-19 variant called B.1621 or mu by the World Health Organization is being monitored by scientists. While this variant is making news, it is not the dominant strain in the U.S. or elsewhere, says Dr. John O'Horo, a Mayo Clinic infectious diseases physician.

    The delta variant is really the predominant strain everywhere at this point. And while it is important that scientists and public health officials keep an eye on this, we're still in a space right now where the mu variant is something to keep an eye on for the future rather than a concern.


    For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.

    FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network.

    FOR THE MEDIA ONLY: Register at to access clean and nat sound versions of this video on the Mayo Clinic News Network.

    Mayo Clinic Follow Mayo Clinic on Instagram: Like Mayo Clinic on Facebook: Follow Mayo Clinic on Twitter:

  • The Delta Variant and Vaccine Protection

    7:09

    What's the deal with Covid variants? How well do the different Covid vaccines protect against the several variants? Today we'll tell you about the several variants, including the Delta variant that is prevalent in the US, and we'll talk about the studies that have looked at vaccine efficacy against these variants.

    Related HCT episodes:
    Alcoholics Anonymous vs Other Treatments:
    Covid Vaccine Passports:

    Be sure to check out our podcast!


    Other Healthcare Triage Links:
    1. Support the channel on Patreon:
    2. Check out our Facebook page:
    3. We still have merchandise available at
    4. Aaron's book The Bad Food Bible: How and Why to Eat Sinfully is available wherever books are sold, such as Amazon:

    Credits:
    Aaron Carroll -- Writer
    Meredith Danko – Social Media
    Tiffany Doherty -- Writer and Script Editor
    John Green -- Executive Producer
    Stan Muller -- Director, Producer
    Mark Olsen – Art Director, Producer
    Eliot Rapoport - Contributing Writer

    #healthcaretriage #covid #deltavariant

  • COVID-19 Update: Vaccine Boosters and the Delta Variant

    5:30

    Rush infectious disease specialist Michael Lin, MD, on COVID-19 vaccine boosters and the ongoing importance of masking up.

  • Delta Variant Versus Previous COVID 19 Infection vs Vaccines Coronavirus Update 128

    16:18

    Roger Seheult, MD of MedCram explains how natural immunity (from a previous COVID-19 infection) compares with vaccines (Pfizer, Moderna, AstraZeneca) VS. the Delta coronavirus variant. (This video was recorded on July 24, 2021).

    Correction: Strasbourg is in France (near the German border), not in Germany.

    TOPICS IN THIS VIDEO INCLUDE:

    00:00 Is natural immunity from previous COVID-19 infection strong enough against Delta variant?
    00:32 Research study of 50,000+ patients from the Cleveland Clinic
    03:07 Qatar airport study shows previous infection with SARS-CoV gives reasonable immunity against reinfection
    05:46 UK data suggests low risk of COVID-19 reinfection among population
    07:04 Study on antibody response effectiveness (from vaccines and natural infection) at neutralizing several COVID-19 variants, including Delta
    13:33 Monoclonal antibodies shown to have little effectiveness against Delta variant
    14:31 Patients urged to get both doses of Pfizer or Moderna, especially for protection against Delta variant
    14:59 MedCram resources for medical providers treating COVID-19 patients and the case for lung ultrasounds

    Roger Seheult, MD is the co-founder and lead professor at
    He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

    See the video Dr. Seheult references about Lung Ultrasound in COVID 19:



    #OFWVietnam #VietnamWonders #PinoyTraveler #ESLTeacher #KayodPinoy #StreetWanderer #SmallYouTuber #WatchtoWatch

    DISCLAIMER: NO COPYRIGHT INFRINGEMENT INTENDED. ALL RIGHTS OF THE MUSIC BELONG TO THE OWNERS, ORIGINAL ARTISTS, PRODUCERS AND RECORD LABELS. THIS VIDEO IS FOR ENTERTAINMENT PURPOSES ONLY.

  • COVID-19 Vaccine: Masks, Delta Variant, Risks and Immunity

    4:59

    Your COVID-19 vaccine questions answered! In this video, Dr. Tara Ralph of MMC Internal and Family Medicine answers the following common questions:

    • What are the current masking recommendations?
    • What is the Delta variant?
    • What is the risk of getting the COVID-19 vaccine versus the risk of getting COVID-19?
    • If I have had COVID-19, how long will my natural immunity last?

    If you have any questions about the COVID-19 vaccine, please reach out to your trusted medical provider. You can sign up to receive the COVID-19 vaccine at

  • Dr. Melanie Swift: COVID-19 vaccine urgency as delta variant continues to spread

    6:55

    Dr. Melanie Swift: COVID-19 vaccine urgency as delta variant continues to spread

    Viruses constantly change through mutation, and new variants of viruses are expected to occur. Multiple variants of the virus that causes COVID-19 have been documented, including a highly transmittable form of COVID-19 known as the delta variant.

    The delta variant, which was first seen in December 2020 in India, is spreading globally. It's more contagious than the previous strains that have been detected in the U.S. It's also causing more severe illness.

    Dr. Melanie Swift, co-chair of Mayo Clinic's COVID-19 Vaccine Allocation and Distribution Work Group, says now is the time to get vaccinated for COVID-19.
    ______________________________

    For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.

    FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network.

    FOR THE MEDIA ONLY: Register at to access clean and nat sound versions of this video on the Mayo Clinic News Network.

    Mayo Clinic
    Like Mayo Clinic on Facebook:
    Follow Mayo Clinic on Twitter:

  • WHO chief criticises Pfizer, Moderna over vaccine strategy as Delta variant drives up Covid cases

    4:43

    World Health Organisation Director General Tedros Adhanom Ghebreyesus warned that Covid-19 cases and related deaths are rising again after some respite. His warning coincided with increased public movement in India following relaxation of restrictions. Ghebreyesus also criticised vaccine-makers Pfizer and Moderna for prioritising jabs for countries with comparatively high vaccine coverage while middle and low-income countries suffer. Watch the full video for more.

    #Covid #WHO #Vaccine

  • Delta variant escapes antibodies gained through vaccination or earlier infection: Study

    1:45

    인도 전문가 델타 변이, 기존 항체 회피 가능

    As the Delta variant, which originated in India continues to spread across the globe, a new study out of India shows the Delta variant can be transmitted to people who have been vaccinated.
    Lee Seung-jae has the details.
    The Delta variant, first identified in India,... has now spread to 80 regions around the world.
    The variant has been deemed highly transmissible,... but now,... studies show the variant is capable of evading antibodies.
    According to a study in India,... which is currently being peer-reviewed,... the Delta variant 'escapes' the antibodies gained by the body either through earlier infection,... or through vaccination.
    The study added its ability to escape antibodies means higher transmissibility,... and this could potentially impact the global vaccination program moving forward.
    With fears over the Delta variant spreading further,... Belgium will ban entry to non-EU travelers from the UK.
    The UK is on a list of 27 nations subject to the ban,... effective June 27th.
    The Delta variant is now the dominant strain in the UK.
    So far in Belgium,... the Delta variant accounts for over 6-percent of infections.
    In China,... hundreds of flights were canceled over the weekend,... when a waitress at Shenzhen International Airport tested positive for the Delta variant.
    Airport authorities are now requesting all travelers submit a negative test that's less than 48 hours old to access the airport,... if the flight hasn't already been canceled.
    Shenzhen is home to large Asian tech companies such as Huawei and Tencent.
    Lee Seung-jae, Arirang News.

    #Delta_variant #COVID19 #Coronavirus

    ???? Arirang News(Facebook) :
    ???? Arirang News(Twitter) :
    ???? News Center(YouTube) :


    2021-06-21, 07:00 (KST)

  • Community Update: Delta Variant

    15:27

    Lynn N. Fitzgibbons, M.D. & Carolina Arias, Ph.D. – 7.8.2021

  • Delta Variant: Why the New Covid is worse | Vaccines, Virulence, and Transmissibility Explained

    14:12

    Description: The Delta variant of SARS-CoV-2, the virus that causes Covid-19, has taken over the world, now accounting for 73% of global cases and rising. Around the world, from the UK to Indonesia to the US, Delta now dominates, making up 99% of the virus circulating in those countries. The US CDC, the WHO, and Public Health England are sounding the alarm on Delta.

    Why are epidemiologists alarmed about the Delta variant? Why are experts warning about Delta? In today’s video, I’m going to review the latest scientific literature to answer that question. In doing so, I’ll address five questions: (1) What is the delta variant? (2) Is delta more infectious or transmissible? (3) Does delta cause more severe illness or death? (4) Are vaccines less effective against delta? (5) And, how does delta change public health policy?

    It’s everything you need to know about Delta with evidence-based science explained!

    Shocking data from a leaked internal CDC report shows that breakthrough infections are not rare and that vaccinated individuals can harbor as much virus as unvaccinated people. The good news is that vaccines can still reduce the risk of hospitalizations and death, even against the delta variant.

    Covid is here to stay. New variants, including the lambda variant in Peru and a new variant called 21H in Colombia, are coming. We still need non-pharmaceutical interventions, including masks and limiting time in crowded indoor spaces. Finally, delta may cause countries like China, Australia, and New Zealand to abandon their Covid strategies.

    0:00 Introduction
    1:13 What is the Delta Variant?
    3:42 Is the Delta Variant more transmissible?
    5:55 Does the Delta Variant cause more severe disease?
    7:52 Are vaccines effective against the Delta Variant?
    11:21 What does this mean for public health policy?




    ****Links to studies and sources of data:

    SARS-CoV-2 variants of concern and variants under investigation in England, Public Health England Technical briefing 19 |

    SARS-CoV-2 Shared Mutations |

    Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development |

    Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic |

    SARS-CoV-2 variants, spike mutations and immune escape | s41579-021-00573-0

    Clinical and Virological Features of SARS-CoV-2 Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta) |

    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant |

    SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough |

    Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage |

    Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada |

    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness |

    Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada |

    Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021 |

  • WHOs Science in 5 on COVID-19: Delta Variant And Vaccines

    4:13

    Do the current batch of approved vaccines protect us from the Delta variant? What is the level of protection? If you can still get infected even after being fully vaccinated, then why should we vaccinate? WHO's Chief Scientist Dr Soumya Swaminathan explains in Science in 5. [Credit: World Health Organisation -

    About Us: NDTV brings you unbiased and comprehensive coverage of news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

    Subscribe to our channels:
    NDTV:
    NDTV India (Hindi News):

    Follow us on Social Media:
    Like us on Facebook:
    Follow us on Twitter:
    Follow us on Instagram:
    Join NDTV on Telegram Messenger:

    Follow us on Google News for Breaking and Latest News Updates:
    NDTV:
    NDTV India (Hindi News):

    Download NDTV Mobile Apps:


    Watch More Videos:


    #BreakingNews #LatestNews #TodayNews #PoliticalNews #News

  • COVID-19 Vaccines, Delta and Immunity | 8-27-21

    54:55

    Presented by:
    Monica Gandhi, MD, MPH
    Division of HIV, Infectious Diseases, and Global Medicine
    University of California San Francisco (UCSF)

    Topics include: COVID vaccines, delta variant, COVID immunology, T cells, B cells, boosters, global vaccine equity

    Additional Resources:
    -
    -
    -
    -

    Part of the National Jewish Health Department of Medicine Grand Rounds Video Series

  • Can unvaccinated people be immune due to a previous COVID infection?

    1:14

    Dr. Dale Bratzler, OU Health chief COVID officer, says natural immunity is real but not helpful at preventing variant infections.

  • COVID-19 Update - Delta Variant Brief and a Call to Action

    5:33

    As the Delta variant causes more cases of COVID-19 nationwide, Dr. Buddy Hammerman and regional medical directors for Select Medical urge everyone to get vaccinated to #StopTheSpread.

  • Andrea Garcia discusses Delta variant and states seeing surges | COVID-19 Update for July 28, 2021

    13:51

    Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, JD, MPH, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering the Delta variant, which states are seeing surges, mask mandates and how to reach the movable middle among Americans yet to be vaccinated.
    Stay up to date on the latest information about the pandemic:
    Visit the COVID-19 Daily Video Updates page for more videos in this series:

  • The Fourth Surge, Delta Variant, Vaccines, Boosters, and More

    1:19:12

    In this special edition of UCSF Department of Medicine Covid-19 Grand Rounds, we’ll discuss the many cross-cutting issues that are making this period in the pandemic so confusing and challenging to navigate. Virologist Shane Crotty of the La Jolla Institute will talk about the Delta variant and what makes it different. He’ll also address the efficacy of vaccines against Delta, the prospect of boosters, and the potential for new variants in the future. Infectious Disease expert Carlos Del Rio of Emory University will describe the current state of the pandemic in the U.S. and worldwide, and offer his perspective on non-pharmacologic interventions (masking, etc), vaccinations, boosters, and our path forward. The session is moderated by UCSF Department of Medicine Chair Bob Wachter.

    Note: Closed captions will be available within 48-72 hours after posting.

    Program
    Bob Wachter: Introduction
    00:04:04-00:22:11 –Delta Variant, Efficacy of Vaccines, Boosters: Shane Crotty (Professor, Center for Infectious Diseases and Vaccine Research, La Jolla Institute for Immunology)
    0:23:06-0:39:28 – State of the Pandemic, Masking, Other Interventions: Carlos Del Rio (Executive Associate Dean, Emory School of Medicine & Grady Health System; Professor of Medicine, Division of Infectious Diseases and Rollins School of Public Health, Emory University)
    0:39:38-1:18:45 – Q&A with Shane Crotty and Carlos Del Rio
    Bob Wachter: Closing

    See previous Covid-19 Medical Grand Rounds:
    • June 17: The Delta Variant, and Lessons from the Pandemic (with Andy Slavitt)
    • June 3: The State of the Pandemic and Strategies to Encourage Vaccination

    • May 20: Roundtable Discussion on New CDC Guidelines, the Current State of the Pandemic, and More

    • May 6: The State of the Pandemic, and Covid-19 and Immunosuppressed Patients


    See all UCSF Covid-19 grand rounds, which have been viewed over 2M times, here:

  • Does the COVID-19 Vaccine Protect Against Variants?

    48

    For more information on the latest COVID-19 variants and mutations, please visit

    The COVID-19 vaccines have protection against every variant, so far. Even with more breakthrough cases reported with the delta variant, the vaccines are effective at preventing serious illness and death.

    #CovidUpdate #CovidVarient #Covid19Vaccine

    ▶Share this video with others:

    ▶Subscribe to learn more about Cleveland Clinic:

Shares

x

Check Also

Menu